Journal article
Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study
- Abstract:
- This study aimed to determine the minimum number of days required to reliably estimate free-living sedentary time, light-intensity physical activity (LPA) and moderate-intensity physical activity (MPA) using accelerometer data in people with Rheumatoid Arthritis (RA), according to Disease Activity Score-28-C-reactive protein (DAS-28-CRP). Secondary analysis of two existing RA cohorts with controlled (cohort 1) and active (cohort 2) disease was undertaken. People with RA were classified as being in remission (DAS-28-CRP < 2.4, n = 9), or with low (DAS-28-CRP ≥ 2.4-≤ 3.2, n = 15), moderate (DAS-28-CRP > 3.2-≤ 5.1, n = 41) or high (DAS-28-CRP > 5.1, n = 16) disease activity. Participants wore an ActiGraph accelerometer on their right hip for 7 days during waking hours. Validated RA-specific cut-points were applied to accelerometer data to estimate free-living sedentary time, LPA and MPA (%/day). Single-day intraclass correlation coefficients (ICC) were calculated and used in the Spearman Brown prophecy formula to determine the number of monitoring days required to achieve measurement reliability (ICC ≥ 0.80) for each group. The remission group required ≥ 4 monitoring days to achieve an ICC ≥ 0.80 for sedentary time and LPA, with low, moderate and high disease activity groups requiring ≥ 3 monitoring days to reliably estimate these behaviours. The monitoring days required for MPA were more variable across disease activity groups (remission = ≥ 3 days; low = ≥ 2 days; moderate = ≥ 3 days; high = ≥ 5 days). We conclude at least 4 monitoring days will reliably estimate sedentary time and LPA in RA, across the whole spectrum of disease activity. However, to reliably estimate behaviours across the movement continuum (sedentary time, LPA, MPA), at least 5 monitoring days are required.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 462.9KB, Terms of use)
-
(Preview, Accepted manuscript, pdf, 462.9KB, Terms of use)
-
- Publisher copy:
- 10.1007/s00296-023-05342-1
- Publication website:
- http://pure-oai.bham.ac.uk/ws/files/196156094/s00296_023_05342_1.pdf
Authors
- Publisher:
- Springer
- Journal:
- Rheumatology International More from this journal
- Volume:
- 43
- Issue:
- 8
- Pages:
- 1459-1465
- Publication date:
- 2023-05-25
- DOI:
- EISSN:
-
1437-160X
- ISSN:
-
0172-8172
- Language:
-
English
- Keywords:
- Pubs id:
-
1347050
- Local pid:
-
pubs:1347050
- Source identifiers:
-
W4378172137
- Deposit date:
-
2026-05-08
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2023
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record